We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
Updated safety advice has been issued to strengthen warnings about potential psychiatric and sexual dysfunction linked to finasteride and to provide precautionary advice on dutasteride.
The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk.
Independent report by the Commission on Human Medicines on the safety implications of a proposal to restrict the availability of puberty blockers for under 18s.
The CMA undertook a review of the retained Vertical Agreements Block Exemption Regulation and has made a recommendation to government on replacing it when it expires in May 2022.
The CMA has reviewed the Public Transport Ticketing Schemes Block Exemption (PTTSBE) to inform its recommendation to government on whether the PTTSBE should be continued, with or without further amendments or whether it should be allowed to expire on 28...
Competition law: information about the review of block exemptions.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).